目的观察阿卡波糖对糖耐量异常患者的治疗效果。
Objective to investigate the therapeutic efficacy of Acarbose on patients with impaired glucose tolerance.
本发明涉及一种以阿卡波糖为活性成份的咀嚼片。
The invention relates to a chewing tablet taking acarbose as an active component.
目的观察胰岛素治疗联合阿卡波糖对血糖波动的影响。
Objective To investigate the effect of combination therapy of insulin and acarbose on glucose excursion in diabetic patients.
总之，我认为，对于糖尿病的预防，阿卡波糖为首选。
So for all those reasons I think that for the prevention of diabetes, Acarbose has to be a priority.
本论文对阿卡波糖的发酵及分离纯化工艺进行了深入的研究。
In this paper, the techniques of fermentation, separation and purification of acarbose were studied.
结论阿卡波糖是降低餐后高血糖的一种有效而安全的降糖药。
Conclusions Acarbose was an effective and safe drug in lowering postprandial hyperglycemia.
用药金额排名前3位的药物是阿卡波糖、格列齐特、格列吡嗪。
The top 3 hypoglycemic drugs in respect of sales amount were acarbose, gliclazide, and glipizide.
结论阿卡波糖能够降低IGT人群糖尿病的发病率，且不增加胰岛素的分泌。
Conclusion Application of acarbose in the intervening treatment of IGT subjects can reduce the incidence of diabetes and without increase the secretion of insulin.
目的探讨阿卡波糖对胃大部切除术后患者出现餐后反应性低血糖的临床疗效。
Objective To evaluate the therapeutic effect of acarbose on reactive hypoglycemia after subtotal gastrectomy.
目的观察阿卡波糖合用六味能消胶囊降低餐后血糖、改善胰岛素敏感性的作用。
To observe the effect of combination therapy of acarbose and Liuwei Nengxiao capsule (LWNXC) in improving senile postprandial hyperglycemia and insulin sensitivity.
它是以阿卡波糖为药用活性成份，与药学上可接受的辅料混合形成的药用组合物。
The acarbose is taken as the medical active component, and the acarbose is mixed with a pharmaceutically acceptable auxiliary material to form the drug composition.
方法：运用CORE糖尿病模型评价阿卡波糖治疗2型糖尿病的长期成本与效果。
METHODS:The CORE diabetes model was employed to evaluate the long-term cost-effectiveness of Acarbose in the treatment of type 2 diabetes.
目的：观察瑞格列奈、阿卡波糖联合治疗老年性2型糖尿病患者的临床疗效及安全性。
Objective: To observe the clinical efficacy and safety of combined treatment of repaglinide and acarbose in aged patients with diabetes type 2.
目的：观察瑞格列奈、阿卡波糖联合治疗老年性2型糖尿病患者的临床疗效及安全性。
Objective: To investigate the causes and clinical features of hypoglycemia in elderly patients with type 2 diabetes.
对于冠心病合并IGT组和单纯IGT组均给予阿卡波糖干预3个月后复测上述指标。
After 3 months 'intervention of Acarbose, we assayed all these indexes of simple IGT and normal control again.
阿卡波糖治疗餐后低血压有效率达62.79%，药物不良反应发生率为9.30%。
The effective rate was 62.79%, and the incidence of adverse drug reaction(ADR) was 9.30%.
目的比较双相胰岛素注射剂（诺和灵30R）单用和联合阿卡波糖治疗2型糖尿病的疗效。
Objective To compare the effects between biphasic insulin injection(Novolin 30R) alone and its therapeutic alliance with acarbose on type 2 diabetes mellitus(T2DM).
目的：观察甘精胰岛素、阿卡波糖与盐酸贝那普利联合治疗2型糖尿病早期肾病的临床疗效。
Objective: To observe the clinical efficacy of insulin glargine, acarbose and benazepril in the combined treatment of early-stage diabetic nephropathy(DN) in type 2 diabetes mellitus(T2DM).
目的：观察甘精胰岛素、阿卡波糖与盐酸贝那普利联合治疗2型糖尿病早期肾病的临床疗效。
Objective: To observe the clinical efficacy of insulin glargine, acarbose and benazepril in the combined treatment of early-stage diabetic nephropathy(DN) in type 2 diabetes mellitus(T2DM).
应用推荐